- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 271/24 - Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
Patent holdings for IPC class C07C 271/24
Total number of patents in this class: 248
10-year publication summary
25
|
14
|
18
|
20
|
19
|
10
|
10
|
8
|
10
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bio-Pharm Solutions Co., Ltd. | 60 |
13 |
Daiichi Sankyo Company, Limited | 1874 |
11 |
Reata Pharmaceuticals Holdings, LLC | 48 |
7 |
Glaxosmithkline Intellectual Property (no.2) Limited | 287 |
5 |
Mitsui Chemicals, Inc. | 3219 |
5 |
The Trustees of Columbia University in the City of New York | 3575 |
5 |
Covestro Deutschland AG | 2748 |
5 |
GE Healthcare Limited | 673 |
5 |
Monash University | 707 |
5 |
Xwpharma Ltd. | 57 |
5 |
Taisho Pharmaceutical Co., Ltd. | 870 |
4 |
Saniona A/S | 48 |
4 |
Novartis AG | 10850 |
3 |
Bristol-myers Squibb Company | 4893 |
3 |
The Regents of the University of California | 19929 |
3 |
Arbutus Biopharma Corporation | 177 |
3 |
BenQ Materials Corporation | 157 |
3 |
Eli Lilly and Company | 3844 |
3 |
Katholieke Universiteit Leuven K.u. Leuven R & D | 211 |
3 |
Korea Research Institute of Chemical Technology | 1390 |
3 |
Other owners | 150 |